Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Seems the CEO is saying that data from the COVID CT can be used to support new CTs for Ifenprodil in the future? ARDS/PF??? Ifenprodil IL-6 effects on tumors? Low O-2?
I also wish CM would mention 'micro-dose' when discussing DMT so as to leave out Psychedelic and separate AGN from the crowd.

"Algernon’s decision will not affect any of its other research programs including investigating Ifenprodil for other disease indications. Algernon has several clinical stage programs currently in progress including a Phase 2 trial of Ifenprodil for idiopathic pulmonary fibrosis and chronic cough. The Company is also planning a Phase 1 clinical trial for the psychedelic drug DMT and stroke by the end of October of this year, as well as a Phase 1 trial for pancreatic cancer in Q1, 2022."

Apparently they have not had the time to review Ifenprodil for stroke or considered combining with micro-dose DMT for preclinical trial. YET? Still holding some BTH shares and watching. Another 'quiet time' until Oct?